125
Participants
Start Date
December 31, 2016
Primary Completion Date
February 28, 2025
Study Completion Date
June 30, 2025
Autologous cell therapy
Autologous cell therapy delivered into the heart muscle using the CardiAMP Cell Therapy System. The CardiAMP Cell Therapy System consists of the CardiAMP Cell Separator, a cardiac delivery catheter, and flexible tip guide catheter.
Sham
An introducer guidewire is placed into the heart and left ventriculography is performed just like it is in the Experimental Arm but no autologous cell therapy is delivered.
New York University School of Medicine, New York
Suburban Hospital, Bethesda
John Hopkins University School of Medicine - Dept of Cardiology, Baltimore
Virginia Commonwealth University (VCU) Medical Center, Richmond
University of Florida - College of Medicine/ div of Cardiovascular Medicine, Gainesville
Morton Plant Mease Health Care, Clearwater
Stern Cardiovascular Foundation, Memphis
Cleveland Clinic, Cleveland
Michigan Heart - St.Joseph Mercy Health System (Trinity Health), Ypsilanti
Henry Ford Hospital, Detroit
Michigan Cardiovascular Institute, Saginaw
Iowa Heart, Des Moines
Oklahoma Heart, Tulsa
University of Colorado, Denver, Aurora
Mayo Clinic, Phoenix
Cedars Sinai Medical Center, Los Angeles
California Pacific Medical Center, San Francisco
Stanford Medical Center, Stanford Health Care, Palo Alto
Atlantic Health System, Morristown
Division of Cardiovascular Medicine, University of Wisconsin Hospital and Clinics, Madison
St. Paul's Hospital, Vancouver
London Health Sciences Center, London
Unity Health Toronto, Toronto
Ottawa Heart Institute, Ottawa
Lead Sponsor
BioCardia, Inc.
INDUSTRY